Drug-induced hepatic injury

Journal of Gastroenterology and Hepatology (Australia)

Volumn 12, Issue 9-10, 1997, Pages

  Farrell, Geoffrey C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Acetaminophen; Adverse drug reaction; Chinese herbal medicines; Diagnosis; Diclofenac; Flucloxacillin; Hepatotoxicity; Methotrexate; Tet racycline

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; BUSULFAN; CHINESE DRUG; CHLORPROMAZINE; CYPROHEPTADINE; DICLOFENAC; ENFLURANE; ERYTHROMYCIN; ESTROGEN; FLUCLOXACILLIN; GLYCYRRHIZIC ACID; HALOPERIDOL; HALOTHANE; HERBACEOUS AGENT; ISONIAZID; METHOTREXATE; METHYLDOPA; MINOCYCLINE; NITROFURANTOIN; PARACETAMOL; PENICILLAMINE; PHENYTOIN; PROCHLORPERAZINE; TETRACYCLINE; TIABENDAZOLE; TIAPROFENIC ACID; TIOGUANINE; TOLBUTAMIDE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

CHINESE HERB; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; DOSE RESPONSE; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; JAUNDICE; LIVER BIOPSY; LIVER TOXICITY; PRIORITY JOURNAL;

EID: 0030736844     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1997.tb00507.x     Document Type: Conference Paper

References (54)

1. Srricker BHCh. Drug-induced hepatic injury. In: Dukes MNG, ed. Drug-induced Disorders, vol. 5. 2nd edn. Amsterdam: Elsevier, 1992; 1-550.
2. Farrell GC. Drug-induced Liver Disease. Edinburgh: Churchill Livingstone, 1994; 1-673.
3. Farrell GC. Liver disease due to drugs, anesthetics and toxins. In: Feldman M, Scharschmidt BF, Sleisenger MH, eds. Sleisenger and Fordtan's Gastrointestinal Diseases, 6th edn. Philadelphia: WB Saunders, 1997; (in press).
4. Lee WM. Drug-induced hepatotoxicity. N. Engl. J. Med. 1995; 333: 1118-27.
5. Bénichou C. Criteria for drug-induced liver disorders. Report of an International Consensus Meeting. J. Hepatol 1990; 11: 272-6.
6. Moulding TS, Redeker AG, Kanel GC. Twenty isoniazid-associated deaths in one state (letter). Ann. Intern. Med. 1991; 114: 431.
7. Meyers B, Halpern M, Sheiner P et al. Acute hepatic failure in seven patients after prophylactic therapy with antituberculous agents. Transplantation 1993; 58: 372-7.
8. Hall P de la M. Histopathology of drug-induced liver diseases. In: Farrell GC. Drug-induced Liver Disease. Edinburgh: Churchill Livingstone, 1994; 115-52.
9. Farrell GC, Weltman D. Drug-induced liver disease. In: Gitnick G, ed. Current Hepatology, vol. 16. Chicago: Mosby-Year Book Medical Publishers, 1996; 143-208.
10. Dreifuss FE. Valproic acid hepatic fatalities: revised table. Neurology (letter). 1989; 39: 1558.
11. Gitlin N. Clinical aspects of liver disease caused by industrial and environmental toxins. In: Zakim D, Boyer TD, eds. Hepatology A Textbook of Liver Disease, 2nd edn. Philadelphia: WB Saunders, 1990; 791-821.
12. Brotodihardjo A, Batey RG, Farrell GC et al. Hepatotoxicity from paracetamol self-poisoning in western Sydney: a continuing challenge. Med. J. Aust. 1992; 157: 382-5.
13. Smilkstein MJ, Knapp GL, Kulig KW et al. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the National Multicentre Study (1976-1985). N. Engl. J. Med. 1988; 319: 1557-62.
14. Moradpour D, Altorfer J, Flury R et al. Chlorpromazineinduced vanishing bile duct syndrome leading to cirrhosis. Hepatology 1994; 20: 1437-41.
15. Piotrowicz A, Polkey M, Wilkinson M. Ursodeoxycholic acid for the treatment of flucloxacillin-associated cholestasis. J. Hepatol. 1995; 22: 119-20.
16. Makin AJ, Wendon J, Williams R. A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993). Gastroenterology 1995; 109: 1907-16.
17. Zimmerman HJ, Maddrey WC. Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instance of therapeutic misadventure. Hepatology 1995; 22: 767-73.
18. Whitcomb DC, Block GD. Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 1994; 272: 1845-50.
19. Crippin JS. Acetaminophen hepatotoxicity. potentiation by isoniazid. Am. J. Gastroenterol. 1993; 88: 590-2.
20. Harrison PM, Wendon JA, Gimson AES, Alexander GJM, Williams R. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N. Engl. J. Med. 1991; 324: 1852-7.
21. Ruymann FB, Mosijczuk AD, Sayers RJ. Hepatoma in a child with methotrexate-induced hepatic fibrosis. JAMA 1977; 238: 2631-3.
22. Zachariae H, Søgaard H. Methotrexate-induced liver cirrhosis: a follow-up. Dermatologica 1987; 175: 178-82.
23. Lewis JH, Schiff ER. Methotrexate-induced chronic liver injury: guidelines for detection and prevention. Am. J. Gastroenterol. 1988; 88: 1337-45.
24. Whiting-O'Keefe QE, Fyfe KH, Sack KD. Methotrexate and histologic hepatic abnormalities: a meta-analysis. Am. J. Med. 1991; 90: 711-6.
25. Kremer JM, Alarcon GS, Lightfoot RW Jr et al. Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. Arth. Rheumat. 1994; 37: 316-28.
26. Weltman D, Samarasinghe D, Farrell GC. Drug-induced liver disease. In: Gitnick G, ed. Current Hepatology, vol. 15. Chicago, Mosby-Year Book Medical Publishers, 1995; 145-95.
27. Larrey D, Vial T, Babany G, Morichau-Beauchant M, Michel H, Benhamou J-P. Hepatitis associated with amoxycillin-clavulanic combination. Report of 15 cases. Gut 1992; 33: 368-71.
28. Kromann-Andersen H, Pedersen A. Reported adverse reactions to and consumption of nonsteroidal antiinflammatory drugs in Denmark over a 17-year period. Dan. Med. Bull. 1988; 35: 187-92.
29. Scully LJ, Clarke D, Bar J. Diclofenac induced hepatitis. 3 cases with features of autoimmune chronic active hepatitis. Dig. Dis. Sci. 1993; 38: 744-51.
30. Iveson TJ, Ryley NG, Kelly PMA et al. Diclofenac associated hepatitis. J. Hepatol. 1990; 10: 85-9.
31. Banks AT, Zimmerman HJ, Ishak KG et al. Diclofenacassociated hepatotoxicity: analysis of 180 cases reported to the Food and Drug Administration as adverse reactions. Hepatology 1995; 22: 820-7.
32. Gough A, Chapman S, Wagstaff K et al. Minocycline induced autoimmune hepatitis and systemic erythematosis-like syndrome. BMJ 1996; 312: 169-72.
33. Hunt CM, Washington K. Tetracycline-induced bile duct paucity and prolonged cholestasis. Gastroenterology 1994; 107: 1844-7.
34. Larrey D, Erlinger S. Drug-induced cholestasis. Balliere's Clin. Gastroenterol. 1988; 2: 423-52.
35. Devereaux BM, Crawford DHG, Purcell P et al. Flucloxacillin associated cholestatic hepatitis. An Australian and Swedish epidemic? Eur. J. Clin. Pharmacol. 1995; 49: 81-5.
36. Fairley CK, McNeil J, Desmond P et al. Risk factors for development of flucloxacillin associated jaundice. BMJ 1993; 306: 233-5.
37. Olsson R, Wiholm B-E, Sand C et al. Liver damage from flucloxacillin, cloxacillin and dicloxacillin. J. Hepatol. 1992; 15: 154-61.
38. Degott C, Feldmann G, Larrey D et al. Drug-induced prolonged cholestasis in adults: a histological semiquantitative study demonstrating progressive ductopenia. Hepatology 1992; 15: 244-51.
39. Koek GH, Sticker BHCh, Blok APR et al. Flucloxacillin-associated hepatic injury. Liver 1994; 14: 225-9.
40. Zafrani ES, Pinaudeau Y, Dhumeaux D. Drug-induced vascular lesions of the liver. Arch. Intern. Med. 1983; 143: 495-502.
41. Valla D, Benhamou J-P. Drug-induced vascular and sinusoidal lesions of the liver. Bailliere's Clin. Gastroenterol. 1988; 2: 481-522.
42. Sterneck M, Weisner R, Ascher N et al. Azathioprine hepatotoxicity after liver transplantation. Hepatology 1991; 14: 806-10.
43. Gane E, Portmann B, Saxena R et al. Nodular regenerative hyperplasia of the liver graft after liver transplantation. Hepatology 1994; 20: 88-94.
44. Duvoux C, Kracht M, Lang P et al. Nodular regenerative hyperplasia of the liver associated with azathioprine therapy. Gastroenterol. Clin. Biol. 1991; 15: 968-73.
45. Ridker PM, McDermott WV. Comfrey herb tea and hepatic veno-occlusive disease. Lancet 1989; 1: 657-8.
46. Kumana CR, Ng M, Lin HJ, Ko W, Wu P-C, Dodd D. Herbal tea induced hepatic veno-occlusive disease: quantification of toxic alkaloid exposure in adults. Gut 1985; 26: 101-4.
47. Woolf GM, Petrovic LM, Roijter SE et al. Acute hepatitis associated with the Chinese herbal product Jin Bu Huan. Ann. Intern. Med. 1994; 121: 729-35.
48. Kane JA, Kane SP, Jain S. Hepatitis induced by traditional Chinese herbs; possible toxic components. Gut 1995; 36: 146-7.
49. Itoh S, Marutani K, Nishijima T et al. Liver injuries induced by herbal medicine, syo-saiko-to (xiao-chai-hutang). Dig. Dis. Sci. 1995; 40: 1845-8.
50. Larrey D, Vial T, Pauwels A et al. Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity. Ann. Intern. Med. 1992; 117: 129-32.
51. Katz M, Saibil F. Herbal hepatitis: subacute hepatic necrosis secondary to chaparral leaf. J. Clin. Gastroenterol. 1990; 12: 203-6.
52. Beuers U, Spengler U, Pape GR. Hepatitis after chronic abuse of senna (letter). Lancet 1991; 337: 372.
53. Delbanco TL. Bitter herbs: mainstream, magic, and menace. Ann. Intern. Med. 1994; 121: 803.
54. Yamashiki M, Nishimura A, Nomoto M et al. Herbal medicine 'Sho-saiko-to' induces tumour necrosis factor-α and granulocyte colony-stimulating factor in vitro in peripheral blood mononuclear cells of patients with hepatocellular carcinoma. J. Gastroenterol. Hepatol. 1996; 11: 137-42.